Reprogramming bladder cancer cells for studying cancer initiation and progression
- 25 July 2016
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (10) , 13237-13245
Abstract
The induced pluripotent stem cell (iPSC) technology is the forced expression of specific transcription factors in somatic cells resulting in transformation into self-renewing, pluripotent cells which possess the ability to differentiate into any type of cells in the human body. While malignant cells could also be reprogrammed into iPSC-like cells with lower efficiency due to the genetic and epigenetic barriers in cancer cells, only a limited number of cancer cell types could be successfully reprogrammed until today. In the present study, we aimed at reprogramming two bladder cancer cell lines HTB-9 and T24 using a non-integrating Sendai virus (SeV) system. We have generated six sub-clones using distinct combinations of four factors—OCT4, SOX2, KLF4 and c-MYC—in two bladder cancer cell lines. Only a single sub-clone, T24 transduced with 4Fs, gave rise to iPSC-like cells. Bladder cancer cell-derived T24 4F cells represent unique features of pluripotent cells such as epithelial-like morphology, colony-forming ability, expression of pluripotency-associated markers and bearing the ability to differentiate in vitro. This is the first study focusing on the reprogramming susceptibility of two different bladder cancer cell lines to nuclear reprogramming. Further molecular characterisation of T24 4F cells could provide a better insight for biomarker research in bladder carcinogenesis and could offer a valuable tool for the development of novel therapeutic approaches in bladder carcinoma.Keywords
Funding Information
- The Scientific and Technological Research Council of Turkey (114S542, 113S927)
This publication has 18 references indexed in Scilit:
- Human Induced Pluripotent Stem Cells from Basic Research to Potential Clinical Applications in CancerBioMed Research International, 2013
- Generation of iPS cells from normal and malignant hematopoietic cellsInternational Journal of Hematology, 2013
- Comparative Proteomic Analysis of Supportive and Unsupportive Extracellular Matrix Substrates for Human Embryonic Stem Cell MaintenanceJournal of Biological Chemistry, 2013
- Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent mannerGenes & Development, 2013
- Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogrammingOncogene, 2012
- Induced pluripotent stem cells: opportunities and challengesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2011
- Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2Nature Protocols, 2010
- Analysis of the distinct functions of growth factors and tissue culture substrates necessary for the long-term self-renewal of human embryonic stem cell linesStem Cell Research, 2009
- Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like stateRNA, 2008
- Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factorsNature, 2008